로딩 중…
지수 로딩 중…
OmniAb, Inc.
OABI· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$1.96-1.01%
2026-08-03
Financials
Valuation Metrics
OmniAb, Inc.'s Market Cap is $284M. At end of 2025 it was $236M. Ranked #2960 of 3,111 in US market (top 95%), #1329 of 1,445 on NASDAQ (top 92%), #243 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 90%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $284M | US#2,960/3,111 Sec#243/269 |
| Revenue | $29M | US#2,902/3,111 Sec#170/269 |
| Net Income | $-54M | US—/3,111 Sec—/269 |
| Total Assets | $294M | US#2,911/3,111 Sec#215/269 |
| Net Assets | $263M | US#2,624/3,111 Sec#174/269 |
| Value | ||
| P/B | 1.08x | US#433/3,111 Sec#22/269 |
| P/S | 9.83x | US#2,659/3,111 Sec#122/269 |
| FCF Yield | -9.16% | US—/3,111 Sec—/269 |
| Profitability | ||
| ROE | -20.67% | US#2,533/3,111 Sec#104/269 |
| ROA | -18.48% | US#2,769/3,111 Sec#121/269 |
| Op. Margin | -200.35% | US#2,864/3,111 Sec#137/269 |
| Revenue Growth | 246.65% | US#56/3,111 Sec#19/269 |
| Financial Health | ||
| Debt Ratio | 11.80% | US#134/3,111 Sec#58/269 |
| Total Debt | $20M | US#2,734/3,111 Sec#185/269 |
| FCF | $-26M | US#2,400/3,111 Sec#98/269 |
| Cash | $29M | US#2,782/3,111 Sec#254/269 |
| Current Ratio | 4.80x | US#493/3,111 Sec#149/269 |
| Performance | ||
| 1Y Return | 2.62% | US#1,903/3,111 Sec#190/269 |
| 1M Return | -19.01% | US#2,771/3,111 Sec#227/269 |
| From 52W High | -29.75% | US#2,066/3,111 Sec#153/269 |
| 1Y MDD | -38.18% | US#1,863/3,111 Sec#137/269 |
| Trading | ||
| Volume | 224,309 shares | US#2,448/3,111 Sec#236/269 |
| Trading Value | $441888.00 | US#3,058/3,111 Sec#263/269 |
| Per Share | ||
| EPS | $-0.51 | US—/3,111 Sec—/269 |
| BPS | $2.09 | US#2,501/3,111 Sec#174/269 |